Filter
368
Filtered Results: 368
Text search:
Yu,
J.
et
al.
Featured
Recommendations
45
New Publications
30
Language
Document type
Guidelines
109
No document type
107
Studies & Reports
98
Manuals
24
Fact sheets
17
Strategic & Response Plan
9
Training Material
1
Situation Updates
1
Resource Platforms
1
Infographics
1
Countries / Regions
Brazil
22
Russia
22
Global
15
Latin America and the Carribbean
11
Germany
11
South Africa
8
Spain
7
Mozambique
6
Middle East and North Africa
6
Ukraine
5
Philippines
5
Argentina
5
Syria
4
Asia
4
Western and Central Europe
4
Vietnam
4
Yemen
4
Angola
4
Colombia
3
Kenya
3
China
3
Peru
3
Africa
3
Eastern Europe and Central Asia
3
Portugal
3
Eastern Europe
3
Ecuador
3
India
3
Ghana
2
Nigeria
2
Italy
2
Guinea-Bissau
2
West and Central Africa
2
South–East Asia Region
2
Western Pacific Region
2
France
2
East and Southern Africa
2
Uganda
2
Tajikistan
1
Switzerland
1
Lesotho
1
Turkey
1
Chile
1
Cameroon
1
Laos
1
Senegal
1
Burkina Faso
1
Malawi
1
Zimbabwe
1
Austria
1
Cambodia
1
Tanzania
1
Jordan
1
Congo, Democratic Republic of
1
Paraguay
1
United Kingdom
1
Lebanon
1
Sudan
1
Mali
1
Botswana
1
South Sudan
1
Indonesia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
113
Clinical Guidelines
23
Public Health
22
Women & Child Health
8
Key Resources
6
Pharmacy & Technologies
6
Capacity Building
1
Toolboxes
COVID-19
130
Mental Health
35
HIV
25
Planetary Health
23
TB
22
Disability
15
AMR
14
NCDs
13
Ebola & Marburg
9
Pharmacy
9
NTDs
9
Rapid Response
7
Refugee
7
Caregiver
7
Health Financing Toolbox
4
Zika
2
Polio
2
Natural Hazards
1
Cholera
1
Global Health Education
1
Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,...
РУКОВОДСТВО ПО
ДОПОЛНЕНИЕ К СВОДНОМУ РУКОВОДСТВУ ПО УСЛУГАМ ТЕСТИРОВАНИЯ НА ВИЧ
ДЕКАБРЬ 2016 г.
УСЛУГИ ТЕСТИРОВАНИЯ НА ВИЧ
Consideraciones para aplicar y ajustar medidas de salud pública y sociales en el contexto de la COVID-19
recommended
orientaciones provisionales, 14 de junio de 2021
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Este documento apresenta uma orientação provisória aos laboratórios e diferentes atores envolvidos na realização de exames laboratoriais para o vírus COVID-19. Ele baseia-se parcialmente na orientação provisória para os exames laboratoriais do coronavírus da Síndrome Respiratória do Ori...
Infection preventions
Hygiene
Guidelines
HIV testing services
July 2015
Child friendly spaces (CFS) are safe spaces where
communities create nurturing environments in which
children can access free and structured play and
learning activities. CFS, also commonly referred to
as Child Centred Spaces or Safe Spaces for Children,
may provide educational and psychosocial...
El presente informe incluye análisis de consultas informales en cinco de las regiones de la OMS: la Región de África, la Región de las Américas (donde se realizaron consultas separadas para el Caribe y América del Norte, y para América Latina), la Región de Asia Sudoriental, la Región de Eu...
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen...
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc...
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
Journal of Infectious Diseases and Therapeutics, 2013, 1, 17-24
16.7.2021
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was first published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during p...
